REVISITING GVL EFFECT OF AZACITIDINE TREATMENT IN RELAPSED MDS PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Cho, S. G. [1 ]
Kim, S. Y. [1 ]
Cho, B. S. [1 ]
Kim, M. [1 ]
Eom, K. S. [1 ]
Kim, Y. J. [1 ]
Kim, H. J. [1 ]
Lee, S. [1 ]
Min, C. K. [1 ]
Kim, D. W. [1 ]
Lee, J. W. [1 ]
Min, W. S. [1 ]
Park, J. W. [1 ]
Kim, C. C. [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0700
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [1] Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine
    Graef, Thorsten
    Kuendgen, Andrea
    Fenk, Roland
    Zohren, Fabian
    Haas, Rainer
    Kobbe, Guido
    LEUKEMIA RESEARCH, 2007, 31 (02) : 257 - 259
  • [2] Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
    El Chaer, Firas
    Borate, Uma
    Dulery, Remy
    Holtan, Shernan G.
    Law, Arjun Datt
    Muffly, Lori
    Nassereddine, Samah
    Shallis, Rory M.
    Stringaris, Kate
    Taylor, Justin
    Devine, Steven M.
    Mohty, Mohamad
    Hourigan, Christopher S.
    BLOOD ADVANCES, 2021, 5 (06) : 1757 - 1759
  • [3] Azacitidine for the treatment of patients with relapsed acute myeloid leukemia after allogeneic stem cell transplantation
    Yoshimoto, Goichi
    Mori, Yasuo
    Kato, Koji
    Odawara, Jun
    Kuriyama, Takuro
    Ueno, Toshiyuki
    Obara, Teppei
    Yurino, Ayano
    Yoshida, Shuro
    Ogawa, Ryosuke
    Ohno, Yuju
    Iwasaki, Hiromi
    Eto, Tetsuya
    Akashi, Koichi
    Miyamoto, Toshihiro
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 2939 - 2948
  • [4] 5-azacitidine is a possible therapeutic option for patients with relapsed AML or MDS after allogeneic stem cell transplantation
    Steckel, N. K.
    Gromke, T.
    Hegerfeldt, Y.
    Hlinka, M.
    Koldehoff, M.
    Ditschkowski, M.
    Elmaagacli, A.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S540 - S541
  • [5] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
    Choi, Yunsuk
    Choi, Eun-Ji
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Jo, Jae-Cheol
    Park, Han-Seung
    Lee, Yoo Jin
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Je-Hwan
    CLINICAL TRANSPLANTATION, 2021, 35 (03)
  • [6] Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.
    Vaughn, Jennifer
    Storer, Barry
    Mielcarek, Marco
    Warren, Edus H., III
    Martin, Paul J.
    Sandmaier, Brenda M.
    Estey, Elihu H.
    Storb, Rainer
    Deeg, H. Joachim
    Scott, Bart Lee
    BLOOD, 2010, 116 (21) : 551 - 551
  • [7] Upfront allogeneic hematopoietic stem cell transplantation for patients with MDS
    Schaefer-Eckart, K.
    Wiener, S.
    Wendelin, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 137 - 137
  • [8] Adoptive immunotherapy ± Ruxolitinib and second allogeneic hematopoietic stem cell transplantation in patients with relapsed Myelofibrosis after allogeneic hematopoietic stem cell transplantation
    Bogdanov, R.
    Ditschkowski, M.
    Steckel, N. -K.
    Klisanin, V.
    Kordelas, L.
    Trenschel, R.
    Beelen, D. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 60 - 61
  • [9] Rescue treatment of patients with relapsed acute leukemia after first allogeneic hematopoietic stem cell transplantation
    Torrent, Anna
    Ferra, Christelle
    Ribera, Josep-Maria
    MEDICINA CLINICA, 2018, 151 (09): : 376 - 377
  • [10] Maintenance therapy with Azacitidine for patients with myeloid malignancies after allogeneic hematopoietic stem cell transplantation
    Linli Lu
    Qian Cheng
    Yuhan Yan
    Xin Chen
    Yishu Tang
    Xin Li
    Scientific Reports, 15 (1)
12345